These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 19386707)

  • 1. Infection of HLA-DR1 transgenic mice with a human isolate of influenza a virus (H1N1) primes a diverse CD4 T-cell repertoire that includes CD4 T cells with heterosubtypic cross-reactivity to avian (H5N1) influenza virus.
    Richards KA; Chaves FA; Sant AJ
    J Virol; 2009 Jul; 83(13):6566-77. PubMed ID: 19386707
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Infection with seasonal influenza virus elicits CD4 T cells specific for genetically conserved epitopes that can be rapidly mobilized for protective immunity to pandemic H1N1 influenza virus.
    Alam S; Sant AJ
    J Virol; 2011 Dec; 85(24):13310-21. PubMed ID: 21976658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct ex vivo analyses of HLA-DR1 transgenic mice reveal an exceptionally broad pattern of immunodominance in the primary HLA-DR1-restricted CD4 T-cell response to influenza virus hemagglutinin.
    Richards KA; Chaves FA; Krafcik FR; Topham DJ; Lazarski CA; Sant AJ
    J Virol; 2007 Jul; 81(14):7608-19. PubMed ID: 17507491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of the antigenic relatedness and cross-protective immunity of the neuraminidase between human influenza A (H1N1) virus and highly pathogenic avian influenza A (H5N1) virus.
    Lu X; Liu F; Zeng H; Sheu T; Achenbach JE; Veguilla V; Gubareva LV; Garten R; Smith C; Yang H; Stevens J; Xu X; Katz JM; Tumpey TM
    Virology; 2014 Apr; 454-455():169-75. PubMed ID: 24725943
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vaccination with Recombinant Parainfluenza Virus 5 Expressing Neuraminidase Protects against Homologous and Heterologous Influenza Virus Challenge.
    Mooney AJ; Gabbard JD; Li Z; Dlugolenski DA; Johnson SK; Tripp RA; He B; Tompkins SM
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28931689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-Reactive Neuraminidase-Inhibiting Antibodies Elicited by Immunization with Recombinant Neuraminidase Proteins of H5N1 and Pandemic H1N1 Influenza A Viruses.
    Liu WC; Lin CY; Tsou YT; Jan JT; Wu SC
    J Virol; 2015 Jul; 89(14):7224-34. PubMed ID: 25948745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells.
    Throsby M; van den Brink E; Jongeneelen M; Poon LL; Alard P; Cornelissen L; Bakker A; Cox F; van Deventer E; Guan Y; Cinatl J; ter Meulen J; Lasters I; Carsetti R; Peiris M; de Kruif J; Goudsmit J
    PLoS One; 2008; 3(12):e3942. PubMed ID: 19079604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Healthy human subjects have CD4+ T cells directed against H5N1 influenza virus.
    Roti M; Yang J; Berger D; Huston L; James EA; Kwok WW
    J Immunol; 2008 Feb; 180(3):1758-68. PubMed ID: 18209073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human CD4+ T cell epitope in the influenza hemagglutinin is cross-reactive to influenza A virus subtypes and to influenza B virus.
    Babon JA; Cruz J; Ennis FA; Yin L; Terajima M
    J Virol; 2012 Sep; 86(17):9233-43. PubMed ID: 22718815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutting edge: CD4 T cells generated from encounter with seasonal influenza viruses and vaccines have broad protein specificity and can directly recognize naturally generated epitopes derived from the live pandemic H1N1 virus.
    Richards KA; Topham D; Chaves FA; Sant AJ
    J Immunol; 2010 Nov; 185(9):4998-5002. PubMed ID: 20889549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influenza Neuraminidase Subtype N1: Immunobiological Properties and Functional Assays for Specific Antibody Response.
    Changsom D; Lerdsamran H; Wiriyarat W; Chakritbudsabong W; Siridechadilok B; Prasertsopon J; Noisumdaeng P; Masamae W; Puthavathana P
    PLoS One; 2016; 11(4):e0153183. PubMed ID: 27054879
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals.
    Lee LY; Ha do LA; Simmons C; de Jong MD; Chau NV; Schumacher R; Peng YC; McMichael AJ; Farrar JJ; Smith GL; Townsend AR; Askonas BA; Rowland-Jones S; Dong T
    J Clin Invest; 2008 Oct; 118(10):3478-90. PubMed ID: 18802496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. M2SR, a novel live influenza vaccine, protects mice and ferrets against highly pathogenic avian influenza.
    Hatta Y; Boltz D; Sarawar S; Kawaoka Y; Neumann G; Bilsel P
    Vaccine; 2017 Jul; 35(33):4177-4183. PubMed ID: 28668565
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunization with cross-conserved H1N1 influenza CD4+ T-cell epitopes lowers viral burden in HLA DR3 transgenic mice.
    Moise L; Tassone R; Latimer H; Terry F; Levitz L; Haran JP; Ross TM; Boyle CM; Martin WD; De Groot AS
    Hum Vaccin Immunother; 2013 Oct; 9(10):2060-8. PubMed ID: 24045788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterosubtypic Protections against Human-Infecting Avian Influenza Viruses Correlate to Biased Cross-T-Cell Responses.
    Zhao M; Liu K; Luo J; Tan S; Quan C; Zhang S; Chai Y; Qi J; Li Y; Bi Y; Xiao H; Wong G; Zhou J; Jiang T; Liu W; Yu H; Yan J; Liu Y; Shu Y; Wu G; Wu A; Gao GF; Liu WJ
    mBio; 2018 Aug; 9(4):. PubMed ID: 30087171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple distinct forms of CD8+ T cell cross-reactivity and specificities revealed after 2009 H1N1 influenza A virus infection in mice.
    Guo H; Topham DJ
    PLoS One; 2012; 7(9):e46166. PubMed ID: 23029425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Virus-like particle vaccine comprised of the HA, NA, and M1 proteins of an avian isolated H5N1 influenza virus induces protective immunity against homologous and heterologous strains in mice.
    Tao P; Luo M; Zhu D; Qu S; Yang Z; Gao M; Guo D; Pan Z
    Viral Immunol; 2009 Jul; 22(4):273-81. PubMed ID: 19594398
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mucosal administration of raccoonpox virus expressing highly pathogenic avian H5N1 influenza neuraminidase is highly protective against H5N1 and seasonal influenza virus challenge.
    Kingstad-Bakke B; Kamlangdee A; Osorio JE
    Vaccine; 2015 Sep; 33(39):5155-62. PubMed ID: 26271828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective pre-priming of HA-specific CD4 T cells restores immunological reactivity to HA on heterosubtypic influenza infection.
    Alam S; Chan C; Qiu X; Shannon I; White CL; Sant AJ; Nayak JL
    PLoS One; 2017; 12(5):e0176407. PubMed ID: 28493882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.